article thumbnail

Three Ways AI, If Trusted, Can Transform the Healthcare Landscape

Healthcare IT Today

Automated chat responses can, for example, help patients get answers to simple medical questions without needing to wait for their doctor to respond, bringing benefits to people and their doctors. We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development.

article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

For the pharmacovigilance space, for example, this automation will begin as a tool for recommendations, suggestions or options for potential safety reports, but it will not fully replace human efforts particularly as there are concerns around data output consistency. Dave Latshaw, CEO at BioPhy 1.

Health IT 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID-19 has accelerated adoption of non-contact patient monitoring technology, says Frost & Sullivan analysis

Healthcare IT News - Telehealth

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. She cites examples such as Binah.ai She cites examples such as Binah.ai THE LARGER CONTEXT.

article thumbnail

Palantir and Healthcare: What could the future hold?

Lloyd Price

Palantir's products are also being used by pharmaceutical companies, medical device manufacturers, and healthcare payers. Some notable examples include: COVID-19 response: Palantir collaborated with various governments and healthcare agencies during the COVID-19 pandemic to provide data integration and analytics support.

article thumbnail

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs.

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

Real-world examples and case studies can showcase the platform's impact. Positive examples will build confidence in the platform's value. Palantir's products are also being used by pharmaceutical companies, medical device manufacturers, and healthcare payers. Palantir's plans for healthcare are ambitious. Buy, build or partner?

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

Transforming healthcare A report from the London School of Economics, The Role of Virtual Health Care and the Pharmaceutical Sector in Improving Population Health , published in 2021, forecast that the pharmaceutical industry would be a core player in all aspects from population health management to preventive and therapeutic care.